Correlation Between Dupont De and Lipigon Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dupont De and Lipigon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Lipigon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Lipigon Pharmaceuticals AB, you can compare the effects of market volatilities on Dupont De and Lipigon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Lipigon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Lipigon Pharmaceuticals.
Diversification Opportunities for Dupont De and Lipigon Pharmaceuticals
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Dupont and Lipigon is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Lipigon Pharmaceuticals AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipigon Pharmaceuticals and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Lipigon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipigon Pharmaceuticals has no effect on the direction of Dupont De i.e., Dupont De and Lipigon Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dupont De and Lipigon Pharmaceuticals
Allowing for the 90-day total investment horizon Dupont De is expected to generate 4.52 times less return on investment than Lipigon Pharmaceuticals. But when comparing it to its historical volatility, Dupont De Nemours is 5.57 times less risky than Lipigon Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Lipigon Pharmaceuticals AB is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 17.00 in Lipigon Pharmaceuticals AB on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Lipigon Pharmaceuticals AB or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Dupont De Nemours vs. Lipigon Pharmaceuticals AB
Performance |
| Timeline |
| Dupont De Nemours |
| Lipigon Pharmaceuticals |
Dupont De and Lipigon Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dupont De and Lipigon Pharmaceuticals
The main advantage of trading using opposite Dupont De and Lipigon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Lipigon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipigon Pharmaceuticals will offset losses from the drop in Lipigon Pharmaceuticals' long position.| Dupont De vs. Eastman Chemical | Dupont De vs. Olin Corporation | Dupont De vs. Cabot | Dupont De vs. Kronos Worldwide |
| Lipigon Pharmaceuticals vs. Sprint Bioscience AB | Lipigon Pharmaceuticals vs. BioArctic AB | Lipigon Pharmaceuticals vs. Veg of Lund | Lipigon Pharmaceuticals vs. Ascelia Pharma AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |